PT - JOURNAL ARTICLE AU - P Hilton AU - K Hertogs AU - S L Stanton TI - The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. AID - 10.1136/jnnp.46.9.854 DP - 1983 Sep 01 TA - Journal of Neurology, Neurosurgery & Psychiatry PG - 854--855 VI - 46 IP - 9 4099 - http://jnnp.bmj.com/content/46/9/854.short 4100 - http://jnnp.bmj.com/content/46/9/854.full SO - J Neurol Neurosurg Psychiatry1983 Sep 01; 46 AB - Sixteen women with multiple sclerosis who complained of nocturia completed a double-blind cross-over trial of Desmopressin (DDAVP) and placebo. Nocturia was reduced from a mean of 2.55 voids to 2.01 with placebo and to 1.28 with Desmopressin (p less than 0.01, for the difference between placebo and Desmopressin). Side effects were minor, and equally distributed between treatment and placebo.